PPIB and disease arising from reactivation of latent virus: Live attenuated Bp and B. mallei batA mutants are among the vaccines with the highest efficacies but, as single deletional mutants, they are probably unsuitable for human use because of concern for possible reversion to virulence and establishment of latent infection.